MedPath

Study on prediction of risk for Diabetes during pregnancy

Not Applicable
Conditions
Health Condition 1: O244- Gestational diabetes mellitus
Registration Number
CTRI/2019/01/017119
Lead Sponsor
Osmania Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1PCOS women non pregnant and pregnant PCOS women with GDM

2.non PCOS GDM

3.healthy controls pregnant and non pregnant.

Exclusion Criteria

Pregestational diabetes

Patients not willing to participate in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To search for biomarkers for predicting the risk of Gestational Diabetes Mellitus early .Timepoint: At the time of recruitment of participants
Secondary Outcome Measures
NameTimeMethod
â?¢Establishment of Biomarker for diagnostic / early diagnostic of GDM and PCOS using body fluids especially serum/plasma, and saliva, by the help of high resolution mass spectrometry and quantitative proteomics and metabolomics. <br/ ><br> <br/ ><br>â?¢Metabolomics biomarker: small molecules, amino acid, carbohydrate, lipid and peptide <br/ ><br> <br/ ><br>â?¢Proteomics Biomarker: Protein <br/ ><br> <br/ ><br>â?¢Validation of biomarker of GDM using Western blot and qPCR <br/ ><br>Timepoint: At the time of recruitment of participants
© Copyright 2025. All Rights Reserved by MedPath